Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 225

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1

Open access
Stuckey, Jacob I, Dickson, Bradley M, Cheng, Nancy, Liu, Yanli, Norris, Jacqueline L, Cholensky, Stephanie H, Tempel, Wolfram, Qin, Su, Huber, Katherine G, Sagum, Cari, Black, Karynne, Li, Fengling, Huang, Xi-Ping, Roth, Bryan L, Baughman, Brandi M, Senisterra, Guillermo, Pattenden, Samantha G, Vedadi, Masoud, Brown, Peter J, Bedford, Mark T, Min, Jinrong, Arrowsmith, Cheryl H, James, Lindsey I, Frye, Stephen V · 2016 · Nature Chemical Biology

Abstract

We report the design and characterization of UNC3866, a potent antagonist of the methyl-lysine (Kme) reading function of the Polycomb CBX and CDY families of chromodomains. Polycomb CBX proteins regulate gene expression by targeting Polycomb Repressive Complex 1 to sites of H3K27me3 via their chromodomains. UNC3866 binds the chromodomains of CBX4 and CBX7 most potently with a Kd of ∼100 nM for each, and is 6- to 18-fold selective versus seven other CBX and CDY chromodomains while being highly selective versus >250 other protein targets. X-ray crystallography revealed that UNC3866 closely mimics the interactions of the methylated H3 tail with these chromodomains. UNC4195, a biotinylated derivative of UNC3866, was used to demonstrate that UNC3866 engages intact PRC1 and that EED incorporation into PRC1 is isoform-dependent in PC3 prostate cancer cells. Finally, UNC3866 inhibits PC3 cell proliferation, a known CBX7 phenotype, while UNC4219, a methylated negative control compound, has negligible effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nchembio.2007

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 51

  1. Wagner, T., Robaa, D., Sippl, W. & Jung, M. Mind the methyl: methyllysine binding proteins in epigenetic regulation. ChemMedChem 9, 466–483 (2014). · DOI
  2. Kaustov, L. et al. Recognition and specificity determinants of the human cbx chromodomains. J. Biol. Chem. 286, 521–529 (2011). · DOI · Paper page
  3. Cao, Q. et al. The central role of EED in the orchestration of polycomb group complexes. Nat. Commun. 5, 3127 (2014). · DOI · Paper page
  4. Vandamme, J., Volkel, P., Rosnoblet, C., Le Faou, P. & Angrand, P.O. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells. Mol. Cell Proteomics 10, M110.002642 (2011). · DOI
  5. Jin, B. et al. Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Rep. 2, 1411–1424 (2012). · DOI
  6. Eskeland, R. et al. Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. Mol. Cell 38, 452–464 (2010). · DOI · Paper page
  7. Bernard, D. et al. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene 24, 5543–5551 (2005). · DOI
  8. Forzati, F. et al. CBX7 is a tumor suppressor in mice and humans. J. Clin. Invest. 122, 612–623 (2012). · DOI
  9. Shinjo, K. et al. Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation. Int. J. Cancer 135, 308–318 (2014). · DOI
  10. Mansueto, G. et al. Identification of a new pathway for tumor progression: microRNA-181b up-regulation and CBX7 down-regulation by HMGA1 protein. Genes Cancer 1, 210–224 (2010). · DOI
  11. Pallante, P. et al. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. Cancer Res. 68, 6770–6778 (2008). · DOI
  12. Pallante, P. et al. The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. Eur. J. Cancer 46, 2304–2313 (2010). · doi:10.1016/j.ejca.2010.05.011
  13. Karamitopoulou, E. et al. Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer. Eur. J. Cancer 46, 1438–1444 (2010). · DOI
  14. Zhang, X.W. et al. Oncogenic role of the chromobox protein CBX7 in gastric cancer. J. Exp. Clin. Cancer Res. 29, 114 (2010). · DOI
  15. Gil, J., Bernard, D., Martínez, D. & Beach, D. Polycomb CBX7 has a unifying role in cellular lifespan. Nat. Cell Biol. 6, 67–72 (2004). · DOI · Paper page
  16. Scott, C.L. et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc. Natl. Acad. Sci. USA 104, 5389–5394 (2007). · DOI · Paper page
  17. Tan, J. et al. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell 20, 563–575 (2011). · DOI · Paper page
  18. Wang, B. et al. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Ann. Surg. Oncol. 20 (suppl. 3): S684–S692 (2013). · DOI
  19. Clermont, P.L. et al. Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role. Br. J. Cancer 111, 1663–1672 (2014). · DOI
  20. Sauvageau, M. & Sauvageau, G. Polycomb group genes: keeping stem cell activity in balance. PLoS Biol. 6, e113 (2008). · DOI
  21. Konze, K.D. et al. An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1. ACS Chem. Biol. 8, 1324–1334 (2013). · DOI · Paper page
  22. Ntziachristos, P. et al. Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature 514, 513–517 (2014). · DOI · Paper page
  23. Simhadri, C. et al. Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7). J. Med. Chem. 57, 2874–2883 (2014). · DOI
  24. Ren, C. et al. Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain. Chem. Biol. 22, 161–168 (2015). · DOI
  25. Frye, S.V. The art of the chemical probe. Nat. Chem. Biol. 6, 159–161 (2010). · DOI · Paper page
  26. Bunnage, M.E., Chekler, E.L. & Jones, L.H. Target validation using chemical probes. Nat. Chem. Biol. 9, 195–199 (2013). · DOI · Paper page
  27. Workman, P. & Collins, I. Probing the probes: fitness factors for small molecule tools. Chem. Biol. 17, 561–577 (2010). · DOI · Paper page
  28. James, L.I. et al. Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain. Nat. Chem. Biol. 9, 184–191 (2013). · DOI · Paper page
  29. Hopkinson, R.J. et al. Is JmjC oxygenase catalysis limited to demethylation? Angew. Chem. Int. Edn. Engl. 52, 7709–7713 (2013). · DOI
  30. Dickson, B.M. Approaching a parameter-free metadynamics. Phys. Rev. E 84, 037701 (2011). · DOI
  31. Muñoz, V., Thompson, P.A., Hofrichter, J. & Eaton, W.A. Folding dynamics and mechanism of β-hairpin formation. Nature 390, 196–199 (1997). · DOI · Paper page
  32. Xiao, Y., Chen, C. & He, Y. Folding mechanism of β-hairpin trpzip2: heterogeneity, transition state and folding pathways. Int. J. Mol. Sci. 10, 2838–2848 (2009). · doi:10.3390/ijms10062838
  33. Fischle, W., Franz, H., Jacobs, S.A., Allis, C.D. & Khorasanizadeh, S. Specificity of the chromodomain Y chromosome family of chromodomains for lysine-methylated ARK(S/T) motifs. J. Biol. Chem. 283, 19626–19635 (2008). · DOI
  34. Kroeze, W.K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362–369 (2015). · DOI · Paper page
  35. Montgomery, N.D., Yee, D., Montgomery, S.A. & Magnuson, T. Molecular and functional mapping of EED motifs required for PRC2-dependent histone methylation. J. Mol. Biol. 374, 1145–1157 (2007). · DOI
  36. Kuzmichev, A., Jenuwein, T., Tempst, P. & Reinberg, D. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Mol. Cell 14, 183–193 (2004). · DOI · Paper page
  37. Ren, X., Vincenz, C. & Kerppola, T.K. Changes in the distributions and dynamics of polycomb repressive complexes during embryonic stem cell differentiation. Mol. Cell. Biol. 28, 2884–2895 (2008). · DOI
  38. Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84–87 (2013). · DOI · Paper page
  39. Li, Q. et al. Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus. PLoS One 5, e13732 (2010). · DOI
  40. Kong, Y., Cui, H., Ramkumar, C. & Zhang, H. Regulation of senescence in cancer and aging. J. Aging Res. 2011, 963172 (2011). · DOI
  41. Jarrard, D.F. et al. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Genes Chromosom. Cancer 19, 90–96 (1997). · DOI · Paper page
  42. Yaqinuddin, A., Qureshi, S.A., Qazi, R. & Abbas, F. Down-regulation of DNMT3b in PC3 cells effects locus-specific DNA methylation, and represses cellular growth and migration. Cancer Cell Int. 8, 13 (2008). · doi:10.1186/1475-2867-8-13
  43. Yaqinuddin, A., Qureshi, S.A., Qazi, R., Farooq, S. & Abbas, F. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness. J. Urol. 182, 756–761 (2009). · doi:10.1016/j.juro.2009.03.082
  44. Mirochnik, Y. et al. Androgen receptor drives cellular senescence. PLoS One 7, e31052 (2012). · DOI
  45. Hess, B., Kutzner, C., van der Spoel, D. & Lindahl, E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 4, 435–447 (2008). · DOI · Paper page
  46. Voter, A.F. Hyperdynamics: accelerated molecular dynamics of infrequent events. Phys. Rev. Lett. 78, 3908–3911 (1997). · DOI · Paper page
  47. Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007). · DOI · Paper page
  48. Wigle, T.J. et al. Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins. J. Biomol. Screen. 15, 62–71 (2010). · DOI
  49. Perfetti, M.T. et al. Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1. ACS Chem. Biol. 10, 1072–1081 (2015). · DOI
  50. Barsyte-Lovejoy, D. et al. (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. Proc. Natl. Acad. Sci. USA 111, 12853–12858 (2014). · DOI · Paper page
  51. Evans, P.R. & Murshudov, G.N. How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 69, 1204–1214 (2013). · DOI · Paper page

Cited by

See all 225

Metadata

Authors
Stuckey, J. I., Dickson, B. M., Cheng, N., Liu, Y., Norris, J. L., Cholensky, S. H., Tempel, W., Qin, S., Huber, K. G., Sagum, C., Black, K., Li, F., Huang, X.-P., Roth, B. L., Baughman, B. M., Senisterra, G., Pattenden, S. G., Vedadi, M., Brown, P. J., Bedford, M. T., Min, J., Arrowsmith, C. H., James, L. I., & Frye, S. V.
Venue
Nature Chemical Biology
Published
2016-01-25
Volume
12
Issue
3
Pages
180-187
ISSN
  • 1552-4450 (ISSN-L)
  • 1552-4469
OpenAlex
W2270756322
Cited by
225
References
9
FWCI
12.04
Type
journal article
Language
en
Update notices
addendum (2019-03-06)
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1. https://app.cochat.ai/papers/10.1038/nchembio.2007
The paper
Stuckey, J. I., Dickson, B. M., Cheng, N., Liu, Y., Norris, J. L., Cholensky, S. H., Tempel, W., Qin, S., Huber, K. G., Sagum, C., Black, K., Li, F., Huang, X.-P., Roth, B. L., Baughman, B. M., Senisterra, G., Pattenden, S. G., Vedadi, M., Brown, P. J., . . . Frye, S. V. (2016). A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1. Nature Chemical Biology. https://doi.org/10.1038/nchembio.2007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.